On the occasion of the next February 4th, World Cancer Daythe IRCCS Foundation National Cancer Institute of Milan renews its commitment in promoting the oncological preventionoffering concrete and free initiatives open to the public.
Vaccinal clinic for oncological patients
Oncological patients, due to the therapies received (chemotherapy, radiotherapy, immunotherapy) and of course the disease itself often present an immune system compromiseresulting more vulnerable to sometimes even trivial infections that can aggravate their state of health and put therapies at risk.
Among the recommended vaccinations for these patients there is above all the Pneumococcal vaccine: prevents serious infections from Streptococcus pneumoniaeresponsible for pneumonia, meningitis and sepsis. In Italy, pneumococcal infections affect thousands of people every year, with a higher incidence between the elderly and immunocompromised subjects.
The vaccine against Herpes Zoster is also recommended to themwhich reduces the risk of developing the Fire of Sant’Antonioa pathology caused by the reactivation of the chickenpox-zoster virus, which can cause severe neuropathic pains and, in some cases, serious complications such as the post-erpetic neuralgia. Herpes Zoster hits about 150 thousand people every year in Italywith a greater prevalence between the over 50s and oncological patients.
Recipients: oncological patients under the IRCCS Foundation National Cancer Institute
Access methods: free, without booking
Hours: 08:30 – 13:30
Place: dedicated clinic (floor -1, under the concierge)
Screening travels to European standards, vaccinations must instead resume because they are falling in the youngest. And males must also be sensitized. Updates on the HPV on the occasion of the dedicated international day
Screening for cervy cancer
The cerler’s neck cancer is one of the most preventable neoplasms thanks to the programs of screening and vaccination. In Italy, about every year they are diagnosed about 2,400 new caseswith a greater impact in women among the 35 and 50 years. In recent decades there has been a significant reduction of both the incidence and the mortality related to this tumor. The standardized rate of incidence went from 14 per 100 thousand women in 1980 to 4 per 100 thousand in 2012, while the mortality that dropped from 7 per 100 thousand women in 1980 to about 2 per 100 thousand in 2012. Currently, net survival at 5 years from the diagnosis it is 68%.
The spread of screening programs and vaccination against human papillomavirus (HPV) have precisely contributed significantly to this positive dynamic, offering effective tools for prevention and early diagnosis
The proposed screening is first based on HPV DNA TESTan examination that detects the presence of Papilloma human virus (HPV)main responsible for the tumor. And then on pap testwhich identifies any pre-tumor cellular alterations, allowing timely interventions to prevent the evolution of the disease.
Recipients: women between 30 and 64 years old
Access methods: free, by reservation (tel. 02.23903755)
Hours: 08:30 – 12:30
Place: gynecology (floor -1, room e)
«Here, where Italian oncology was born – he underlines Gustavo Galmozzipresident of the IRCCS Foundation National Cancer Institute of Milanthe commitment in the health and care of patients continues every day, also through free awareness and prevention activities for the community ».
Source: Vanity Fair
I’m Susan Karen, a professional writer and editor at World Stock Market. I specialize in Entertainment news, writing stories that keep readers informed on all the latest developments in the industry. With over five years of experience in creating engaging content and copywriting for various media outlets, I have grown to become an invaluable asset to any team.
